L26/P-481 Aging of human endometrium impairs clinical pregnancy outcomes in patients attempting assisted reproduction technology treatment
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.814 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Wang.
Abstract (Originalsprache)
Study question To explore the impact of endometrium aging on female fertility and pregnancy outcomes. Summary answer After adjusting for potential confounders, endometrial aging negatively affected clinical outcomes, including decreased biochemical pregnancy rate, clinical pregnancy rate, and live birth rate. What is known already Due to the heterogeneity in study design, selection of donors, clinical and demographic characteristics of recipients, as well as the interference of potential confounders, the conclusions regarding the efficacy of oocyte donation in elderly patients and whether endometrium aging could affect pregnancy outcomes are controversial Study design, size, duration A single-center retrospective case-control study conducted in a university-affiliated hospital. Embryo transfer cycles from January 2013 to June 2024 were enrolled. The participants were those who underwent at least two embryo transfers during this period. Participants/materials, setting, methods These embryos were derived from the oocytes of the same oocyte retrieval cycle. Meanwhile, the time interval between the previous and following embryo transfer cycles was more than 36 months. The previous cycles were the control group, and the following cycles were the exposure group. Pregnancy outcomes, including implantation rate, biochemical pregnancy rate, clinical pregnancy rate, early miscarriage rate, and live birth rate were compared between the previous and following embryo transfer cycles. Main results and the role of chance A total of 2,008 cycles from 654 couples were enrolled in the final analyses, with 877 cycles in the control group and 1,131 cycles in the exposure group. After adjustment for the influence of potential confounders using logistic regression analyses, the likelihood of biochemical pregnancy (adjusted OR 0.60, 95% CI (0.46, 0.77), P<0.001,), clinical pregnancy (adjusted OR 0.49, 95% CI (0.38, 0.63), P<0.001) and live birth rate (adjusted OR 0.52, 95% CI (0.41, 0.66), P < 0.001) was significantly decreased in the exposure group. Frozen embryo transfer cycles with single blastocyst of good quality were included in a subgroup analysis, in which artificial endometrium preparation protocols were employed. The control group comprised 144 cycles, while the exposure group consisted of 163 cycles. The clinical outcomes of the following embryo transfer cycles appeared to be inferior, with a notable decrease in the implantation rate (P<0.001), biochemical pregnancy rate (P<0.001), clinical pregnancy rate (P<0.001), and live birth rate (P<0.001). Limitations, reasons for caution The design of the self-control study was the primary strength of this study. A multi-center prospective study with a larger sample size is imperative. Wider implications of the findings This study highlights that advanced age in women affects pregnancy by affecting endometrial function as well, apart from ovarian reserve. Trial registration number No
Zitieren
APA
Wang, M. (2026). L26/P-481 Aging of human endometrium impairs clinical pregnancy outcomes in patients attempting assisted reproduction technology treatment. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.814
Vancouver
Wang M. L26/P-481 Aging of human endometrium impairs clinical pregnancy outcomes in patients attempting assisted reproduction technology treatment. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.814
BibTeX
@article{Wang2026,
author = {Wang, M.},
title = {L26/P-481 Aging of human endometrium impairs clinical pregnancy outcomes in patients attempting assisted reproduction technology treatment},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.814}
}
EUVIMED